Searchable abstracts of presentations at key conferences in endocrinology

ea0044p234 | Thyroid | SFEBES2016

Serum thyroid function, mortality and disability in a cohort of 85 year olds

Razvi Salman , Yadegarfar Mohammad , Martin-Ruiz Carmen , Kingston Andrew , Collerton Joanna , Visser Theo , Kirkwood Tom , Jagger Carol , Pearce Simon

Perturbations in thyroid function are common in older individuals but their significance in the very old is not fully understood. We examined thyroid hormone status (serum TSH, FT4, FT3, rT3) at baseline in a cohort of 643 85-year-olds and followed their mortality and disability outcomes for 9 years. All cause mortality, cardiovascular mortality and disability according to categorical thyroid disease status and baseline thyroid hormone paramete...

ea0037gp.30.04 | Endocrine tumours and neoplasia – General | ECE2015

Re-introduction of type 1 iodothyronine deiodinase in renal cancer cells affects their migration and expression of adhesion-related genes

Poplawski Piotr , Boguslawska Joanna , Kedzierska Hanna , Rybicka Beata , Tanski Zbigniew , Visser Theo J , Nauman Alicja , Piekielko-Witkowska Agnieszka

Introduction: Type 1 iodothyronine deiodinase (DIO1) is one of the three enzymes regulating bioavailability of thyroid hormones. In contrast to DIO2 and DIO3, the specific cellular role of DIO1 remains controversial. Our previous studies showed that DIO1 expression in clear cell renal cell carcinoma (ccRCC) is decreased, followed by lowered intracellular T3 concentration. In this study we explored how re-introduction of DIO1 in ccRCC cells affects their mig...

ea0035p634 | Female reproduction | ECE2014

Mice lacking anti-Müllerian hormone signaling are protected against the age-related decline in metabolism

van Houten E Leonie A F , Hoek Jeffrey , Kramer Piet , McLuskey Anke , Karels Bas , Themmen Axel P N , Visser Jenny A

Polycystic ovary syndrome (PCOS) is a disorder associated with infertility and metabolic disturbances. Ovaries of PCOS women contain an increased number of growing follicles. Such an ovarian phenotype is also observed in mice lacking the ovary-specific growth factor anti-Müllerian hormone (AMH). To determine the interaction between ovarian and metabolic function, we studied the metabolic phenotype of mice lacking AMH signaling as a model for an altered profile in ovarian ...

ea0026oc1.1 | Thyroid/Adrenal | ECE2011

ESE Young Investigator Award

Medici M , Timmermans S , Jaddoe V , Hofman A , de Rijke Y , Tiemeier H , Peeters R , Visser T , Steegers Eric

Introduction: Maternal hypo- and hyperthyroidism during pregnancy have been associated with high and low birth weights, which predispose for various diseases later in life, such as cardiovascular diseases and cancer. However, the effects of variation in maternal thyroid hormone levels within the normal range on fetal growth and birth weight are largely unknown.Methods: First trimester serum TSH, FT4 and TPO-antibody (TPOab) levels were determi...

ea0016s20.3 | Translational highlights | ECE2008

Monoallelic mutations in DUOXA2 are associated with mild permanent hypothyroidism and goiter

Ventura Paula , Azcona Cristina , Clemente Maria , Albisu Marian , Audi Laura , Carrascosa Antonio , Visser Theo , Moreno Jose C

Generation of H2O2 at the apical membrane of thyroid cells is essential for iodination of thyroglobulin. Dual oxidase 2 (DUOX2) is the catalytic core of the thyroidal H2O2 generator, and its deficiency leads to congenital hypothyroidism (CH) in humans and mice. The Dual oxidase maturation factor 2 (DUOXA2) is a recently identified endoplasmic reticulum (ER)-resident protein required for expression of DUOX2 activity.<p class="abst...

ea0016p124 | Clinical cases | ECE2008

Increased levels of thyroid hormone and a non-suppressed TSH in two patients due to different mutations in T3 receptor beta (TRβ)

Peeters Robin , Sorensen Helena , Keularts Irene , Oldenburg Christine , Oranje Wilma , Postema Pieter , van der Deure Wendy , Visser Theo

Introduction: Resistance to thyroid hormone (TH) can be caused by a failure of TH to enter the cell, or by a lack of action of intracellular TH.Cases: Patient A, a 60-year-old man, presented with an elevated TSH (15.8 mU/l (reference range: 0.4–4.3 mU/l)), an elevated FT4 (29.5 pmol/l (11–25 pmol/l)), and a normal T3. Reverse T3 (rT3), the inactive metabolite of T4, was clearly elevated (0.82 nmol/l (0.14–0.34 nmol/l)). His medical history...

ea0008oc13 | Neuroendocrinology and Reproduction | SFE2004

Reduced expression of anti-Mullerian hormone (AMH) protein in the androgenised sheep ovary

Bull L , Stubbs S , Birch R , Robinson J , Themmen AP , Visser JA , Groome NP , Hardy K , Franks S

The prenatally androgenised sheep, like the Rhesus monkey, is an informative model for polycystic ovary syndrome (PCOS). We have recently demonstrated that AMH protein is reduced in preantral follicles of PCOS ovaries (Stubbs et al, Endocrine Abstracts 2004, 7 P186 ). We hypothesized that reduced expression of AMH is an effect of androgen excess. The aim of this study was to examine AMH immunostaining in ovaries from prenatally androgen-treated and control ewes. Ovaries were t...

ea0007p186 | Reproduction | BES2004

Anti-Mullerian hormone (AMH) protein expression in normal and polycystic human ovaries

Stubbs S , Webber L , Flanagan A , Da|#Silva-Buttkus P , Themmen A , Visser J , Groome N , Hardy K , Franks S

Anti-Mullerian hormone (AMH) is expressed in the ovary, in granulosa cells (GC) of preantral and antral follicles. Mice lacking the AMH gene show an increase in the proportion of early growing follicles and a reciprocal decrease in the primordial pool, suggesting an important role in early follicle growth. Little is known about the expression of AMH in the human ovary. Recent studies have shown that the proportion of follicles entering the growing pool is increased in PCO, sim...

ea0056p1135 | Thyroid cancer | ECE2018

Improved prognostic value of the eighth edition of the AJCC/TNM staging system for differentiated thyroid cancer

van Velsen Evert , Stegenga Merel , van Kemenade Folkert , Kam Boen , van Ginhoven Tessa , Visser W Edward , Peeters Robin

Background: In January 2018, the 8th edition of the AJCC/TNM staging system for differentiated thyroid cancer (DTC) was introduced in clinical practice. Studies evaluating this 8th edition so far only comprised patients with papillary thyroid cancer (PTC) or made no distinction between PTC and follicular thyroid cancer (FTC). Therefore, we evaluated the prognostic value of the AJCC/TNM 8th edition in a European population with DTC, and subsequently distinguished PTC and FTC pa...

ea0073aep664 | Thyroid | ECE2021

How Does Age Influence Disease Outcome in High Risk Papillary and Follicular Thyroid Cancer Patients?

Van Velsen Evert , Peeters Robin , Stegenga Merel , van Kemenade Folkert , van Ginhoven Tessa , Verburg Frederik , W. Edward Visser

BackgroundThe 2015 American Thyroid Association (ATA) Risk Stratification System for differentiated thyroid cancer (DTC) is designed to predict response to therapy and recurring disease. Although age is not incorporated as a risk factor, recent research suggests that the addition of age can improve this system. However, these studies comprised low number of patients with ATA High Risk, low numbers of patients with follicular thyroid cancer (FTC), and did...